2.
72例肺腺鳞癌患者的术前诊断和术后病理
Preoperative diagnosis and postoperative pathology in 72 cases of patients with ASC
Pathological characteristics | n | Percentage (%) |
SC: squamous cell carcinoma; AC: adenocarcinoma; NSCLC: non-small cell lung cancer; WT: wild type. | ||
Preoperative diagnosis | ||
SC | 16 | 29.6 (16/54) |
AC | 15 | 27.8 (15/54) |
NSCLC | 6 | 11.1 (6/54) |
Poorly differentiated carcinoma | 1 | 1.9 (1/54) |
No cancer cell | 10 | 18.5 (10/54) |
ASC | 6 | 11.1 (6/54) |
Visceral pleural invasion | ||
Yes | 51 | 87.9 (51/58) |
No | 7 | 12.1 (7/58) |
Tumor | ||
T1 | 5 | 8.6 (5/58) |
T2 | 41 | 70.7 (41/58) |
T3 | 10 | 17.2 (10/58) |
T4 | 2 | 3.5 (2/58) |
Nodes | ||
N0 | 22 | 37.9 (22/58) |
N1 | 10 | 17.2 (10/58) |
N2 | 24 | 41.4 (24/58) |
N3 | 2 | 3.5 (2/58) |
Metastasis | ||
M0 | 61 | 84.7 (61/72) |
M1 | 11 | 15.3 (11/72) |
TNM stage | ||
Stage Ⅰ | 17 | 23.6 (17/72) |
Stage Ⅰa | 3 | 4.2 (3/72) |
Stage Ⅰb | 14 | 19.4 (14/72) |
Stage Ⅱ | 13 | 18.1 (13/72) |
Stage Ⅱa | 10 | 13.9 (10/72) |
Stage Ⅱb | 3 | 4.2 (3/72) |
Stage Ⅲ | 31 | 43.1 (31/72) |
Stage Ⅲa | 27 | 37.5 (27/72) |
Stage Ⅲb | 4 | 5.6 (4/72) |
Stage Ⅳ | 11 | 15.3 (11/72) |
Gene test (mutations) | 33 | |
EGFR 19 | 10 | 30.3 (10/33) |
EGFR 20 and EGFR 21 | 1 | 3.0 (1/33) |
EGFR 21 | 6 | 18.2 (6/33) |
KRAS 12 | 2 | 6.1 (2/33) |
ALK | 2 | 6.1 (2/33) |
HER2 | 1 | 3.0 (1/33) |
WT | 11 | 33.3 (11/33) |